Suppr超能文献

对具有复制能力的HIV-1储存库进行配对定量和定性评估,并与整合的前病毒DNA进行比较。

Paired quantitative and qualitative assessment of the replication-competent HIV-1 reservoir and comparison with integrated proviral DNA.

作者信息

Lorenzi Julio C C, Cohen Yehuda Z, Cohn Lillian B, Kreider Edward F, Barton John P, Learn Gerald H, Oliveira Thiago, Lavine Christy L, Horwitz Joshua A, Settler Allison, Jankovic Mila, Seaman Michael S, Chakraborty Arup K, Hahn Beatrice H, Caskey Marina, Nussenzweig Michel C

机构信息

Laboratory of Molecular Immunology, The Rockefeller University, New York, NY 10065.

Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104.

出版信息

Proc Natl Acad Sci U S A. 2016 Dec 6;113(49):E7908-E7916. doi: 10.1073/pnas.1617789113. Epub 2016 Nov 21.

Abstract

HIV-1-infected individuals harbor a latent reservoir of infected CD4 T cells that is not eradicated by antiretroviral therapy (ART). This reservoir presents the greatest barrier to an HIV-1 cure and has remained difficult to characterize, in part, because the vast majority of integrated sequences are defective and incapable of reactivation. To characterize the replication-competent reservoir, we have combined two techniques, quantitative viral outgrowth and qualitative sequence analysis of clonal outgrowth viruses. Leukapheresis samples from four fully ART-suppressed, chronically infected individuals were assayed at two time points separated by a 4- to 6-mo interval. Overall, 54% of the viruses emerging from the latent reservoir showed gp160 env sequences that were identical to at least one other virus. Moreover, 43% of the env sequences from viruses emerging from the reservoir were part of identical groups at the two time points. Groups of identical expanded sequences made up 54% of proviral DNA, and, as might be expected, the sequences of replication-competent viruses in the active reservoir showed limited overlap with integrated proviral DNA, most of which is known to represent defective viruses. Finally, there was an inverse correlation between proviral DNA clone size and the probability of reactivation, suggesting that replication-competent viruses are less likely to be found among highly expanded provirus-containing cell clones.

摘要

感染HIV-1的个体体内存在潜伏的感染性CD4 T细胞库,抗逆转录病毒疗法(ART)无法根除该细胞库。这个细胞库是治愈HIV-1的最大障碍,并且一直难以表征,部分原因是绝大多数整合序列存在缺陷且无法重新激活。为了表征具有复制能力的细胞库,我们结合了两种技术,即定量病毒增殖和对克隆增殖病毒进行定性序列分析。在间隔4至6个月的两个时间点,对来自四名长期接受ART抑制的慢性感染个体的白细胞分离样本进行了检测。总体而言,从潜伏细胞库中产生的病毒中有54%显示出与至少一种其他病毒相同的gp160 env序列。此外,在两个时间点,从细胞库中产生的病毒的env序列中有43%属于相同的组。相同的扩增序列组占前病毒DNA的54%,正如预期的那样,活跃细胞库中具有复制能力的病毒序列与整合的前病毒DNA的重叠有限,其中大部分已知代表缺陷病毒。最后,前病毒DNA克隆大小与重新激活的可能性呈负相关,这表明在高度扩增的含前病毒细胞克隆中不太可能发现具有复制能力的病毒。

相似文献

1
Paired quantitative and qualitative assessment of the replication-competent HIV-1 reservoir and comparison with integrated proviral DNA.
Proc Natl Acad Sci U S A. 2016 Dec 6;113(49):E7908-E7916. doi: 10.1073/pnas.1617789113. Epub 2016 Nov 21.
3
Genotypic and Phenotypic Diversity of the Replication-Competent HIV Reservoir in Treated Patients.
Microbiol Spectr. 2022 Aug 31;10(4):e0078422. doi: 10.1128/spectrum.00784-22. Epub 2022 Jun 30.
4
Proviral Turnover During Untreated HIV Infection Is Dynamic and Variable Between Hosts, Impacting Reservoir Composition on ART.
Front Microbiol. 2021 Aug 19;12:719153. doi: 10.3389/fmicb.2021.719153. eCollection 2021.
7
New Frontiers in Measuring and Characterizing the HIV Reservoir.
Front Microbiol. 2019 Dec 18;10:2878. doi: 10.3389/fmicb.2019.02878. eCollection 2019.
8
Expanded cellular clones carrying replication-competent HIV-1 persist, wax, and wane.
Proc Natl Acad Sci U S A. 2018 Mar 13;115(11):E2575-E2584. doi: 10.1073/pnas.1720665115. Epub 2018 Feb 26.
9
Development of 5' LTR DNA methylation of latent HIV-1 provirus in cell line models and in long-term-infected individuals.
Clin Epigenetics. 2016 Feb 19;8:19. doi: 10.1186/s13148-016-0185-6. eCollection 2016.

引用本文的文献

1
Applications and limitations of the passenger hypothesis for HIV reservoir persistence and cure.
J Virol. 2025 Jul 22;99(7):e0071425. doi: 10.1128/jvi.00714-25. Epub 2025 Jun 4.
2
Phenotyping Viral Reservoirs to Reveal HIV-1 Hiding Places.
Curr HIV/AIDS Rep. 2025 Feb 4;22(1):15. doi: 10.1007/s11904-025-00723-6.
3
Current methods for detecting and assessing HIV-1 antibody resistance.
Front Immunol. 2025 Jan 6;15:1443377. doi: 10.3389/fimmu.2024.1443377. eCollection 2024.
4
Transcription of HIV-1 at sites of intact latent provirus integration.
J Exp Med. 2024 Sep 2;221(9). doi: 10.1084/jem.20240391. Epub 2024 Aug 14.
5
Sustained aviremia despite anti-retroviral therapy non-adherence in male children after in utero HIV transmission.
Nat Med. 2024 Oct;30(10):2796-2804. doi: 10.1038/s41591-024-03105-4. Epub 2024 Jun 6.
6
Transcription of HIV-1 at sites of intact latent provirus integration.
bioRxiv. 2024 Apr 29:2024.04.26.591331. doi: 10.1101/2024.04.26.591331.
8
The cell biology of HIV-1 latency and rebound.
Retrovirology. 2024 Apr 5;21(1):6. doi: 10.1186/s12977-024-00639-w.
9
CD4+ T cells with latent HIV-1 have reduced proliferative responses to T cell receptor stimulation.
J Exp Med. 2024 Mar 4;221(3). doi: 10.1084/jem.20231511. Epub 2024 Jan 25.
10
HIV Expression in Infected T Cell Clones.
Viruses. 2024 Jan 11;16(1):108. doi: 10.3390/v16010108.

本文引用的文献

1
Effect of HIV Antibody VRC01 on Viral Rebound after Treatment Interruption.
N Engl J Med. 2016 Nov 24;375(21):2037-2050. doi: 10.1056/NEJMoa1608243. Epub 2016 Nov 9.
2
Quantification of the Latent HIV-1 Reservoir Using Ultra Deep Sequencing and Primer ID in a Viral Outgrowth Assay.
J Acquir Immune Defic Syndr. 2017 Feb 1;74(2):221-228. doi: 10.1097/QAI.0000000000001187.
3
Broad activation of latent HIV-1 in vivo.
Nat Commun. 2016 Sep 8;7:12731. doi: 10.1038/ncomms12731.
4
Defective proviruses rapidly accumulate during acute HIV-1 infection.
Nat Med. 2016 Sep;22(9):1043-9. doi: 10.1038/nm.4156. Epub 2016 Aug 8.
5
Evaluating Clonal Expansion of HIV-Infected Cells: Optimization of PCR Strategies to Predict Clonality.
PLoS Pathog. 2016 Aug 5;12(8):e1005689. doi: 10.1371/journal.ppat.1005689. eCollection 2016 Aug.
6
HIV-1 antibody 3BNC117 suppresses viral rebound in humans during treatment interruption.
Nature. 2016 Jul 28;535(7613):556-60. doi: 10.1038/nature18929. Epub 2016 Jun 22.
7
Enhanced clearance of HIV-1-infected cells by broadly neutralizing antibodies against HIV-1 in vivo.
Science. 2016 May 20;352(6288):1001-4. doi: 10.1126/science.aaf1279. Epub 2016 May 5.
8
What Integration Sites Tell Us about HIV Persistence.
Cell Host Microbe. 2016 May 11;19(5):588-98. doi: 10.1016/j.chom.2016.04.010.
9
Elimination of HIV-1-infected cells by broadly neutralizing antibodies.
Nat Commun. 2016 Mar 3;7:10844. doi: 10.1038/ncomms10844.
10
HIV-1 Reservoirs During Suppressive Therapy.
Trends Microbiol. 2016 May;24(5):345-355. doi: 10.1016/j.tim.2016.01.006. Epub 2016 Feb 12.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验